Alignment Healthcare Reports Strong 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 26 2026
0mins
Should l Buy ALHC?
Source: Yahoo Finance
- Significant Revenue Growth: Alignment Healthcare reported full-year revenue of $3.95 billion for 2025, representing a 46.1% year-over-year increase, exceeding expectations and demonstrating strong performance in the Medicare Advantage market, thereby solidifying its market position.
- Strong Membership Growth: By the end of Q4 2025, health plan membership reached approximately 236,300, a 25.0% increase year-over-year, which not only enhances the company's market share but also lays a solid foundation for future revenue growth.
- Improved Profitability: The adjusted gross profit for 2025 was $494.8 million, with an operating income of $14.8 million; although there was still a net loss, the company made positive strides in profitability and margin expansion, indicating the sustainability of its business model.
- Optimistic Outlook: The company anticipates revenue for 2026 to reach between $5.14 billion and $5.19 billion, reflecting a year-over-year growth of 30%-31%, with adjusted EBITDA guidance set at $133 million to $163 million, showcasing management's confidence in future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALHC
Wall Street analysts forecast ALHC stock price to rise
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 16.620
Low
18.00
Averages
21.81
High
30.00
Current: 16.620
Low
18.00
Averages
21.81
High
30.00
About ALHC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alignment Healthcare CEO Sells 118,000 Shares for $2.06 Million
- Transaction Overview: Alignment Healthcare CEO John E. Kao sold 118,000 shares indirectly for approximately $2.06 million, with the sale price based on SEC Form 4 at $17.48 per share, indicating stable market conditions at the time of sale.
- Ownership Structure Change: Post-transaction, Kao retains 1,784,868 shares directly and 2,354,641 shares indirectly, maintaining a total beneficial ownership of 4,139,509 shares, reflecting his ongoing confidence and control over the company.
- Historical Trading Comparison: The 118,000 shares sold are below the recent median sell size of 180,000 shares since May 2025 and below the maximum single-trade size of 605,648 shares, demonstrating the consistency of his trading activity.
- Company Growth Outlook: The company reported full-year revenue of approximately $3.95 billion in 2025, up over 46% year-over-year, with projected revenue for 2026 expected to reach $5.1 billion to $5.2 billion, highlighting strong membership growth and the focus on improving profitability despite thin margins.
See More
Alignment Healthcare CEO Sells 118,000 Shares for $2.06 Million
- Indirect Share Sale: Alignment Healthcare CEO John E. Kao sold 118,000 shares indirectly through the JEK Trust on March 23, 2026, generating approximately $2.06 million, reflecting his routine selling activity under a prearranged trading plan.
- Updated Holdings: Post-transaction, Kao's indirect holdings stand at 2,354,641 shares and direct holdings at 1,784,868 shares, maintaining over 4.1 million shares overall, indicating his continued confidence in the company's future.
- Strong Financial Performance: The company reported full-year revenue of about $3.95 billion in 2025, up more than 46% year-over-year, with adjusted EBITDA of roughly $110 million, marking a significant step towards achieving positive free cash flow.
- Growth and Profitability Challenges: While membership growth remains robust with projected revenue of $5.1 billion to $5.2 billion in 2026, the company must prioritize margin improvement to ensure a balance between sustained growth and profitability.
See More
Alignment Healthcare Prices Public Offering of 13.17M Shares
- Offering Size: Alignment Healthcare announced a public offering of 13,167,733 shares at $19.46 each, facilitated by General Atlantic, L.P., indicating ongoing market interest despite the company not receiving any proceeds from the sale.
- Closing Timeline: The offering is expected to close on March 4, 2026, pending standard closing conditions, which may influence short-term investor decisions and market liquidity.
- Financial Performance Overview: In its latest earnings report, Alignment Healthcare reported a GAAP EPS of -$0.05, beating expectations by $0.10, with revenue of $1.02 billion exceeding forecasts by $20 million, demonstrating some financial resilience amid market pressures.
- Market Competition Dynamics: Despite strong performance, the slowdown in Medicare Advantage growth, coupled with the retreat of UnitedHealth and CVS, may pose challenges to Alignment Healthcare's future growth, necessitating close monitoring of industry trends.
See More
Alignment Healthcare Prices Public Offering of 13.17 Million Shares
- Public Offering Pricing: Alignment Healthcare announced the pricing of 13,167,733 shares at $19.46 each, with the company not receiving any proceeds, yet this move is expected to enhance market liquidity.
- Underwriter Role: J.P. Morgan is acting as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions, reflecting market confidence in the company.
- Registration Statement Validity: The offering is made pursuant to a shelf registration statement on Form S-3, which became effective on March 2, 2026, ensuring the company's compliance and transparency in capital markets.
- Future Outlook: Although the offering does not directly generate funds for the company, it is anticipated to bolster market visibility and liquidity, laying the groundwork for future expansion and market entry.
See More
ALIGNMENT HEALTHCARE INC - REVEALS SHARE OFFERING PRICE OF $19.46 FOR 13,167,733 SHARES
- Announcement of Share Offering: Alignment Healthcare Inc. has announced a share offering of 13,167,733 shares.
- Pricing Details: The shares are being offered at a price of $19.46 per share.
See More
Alignment Healthcare Launches Public Offering of 13.17 Million Shares
- Public Offering Initiated: Alignment Healthcare announced the commencement of a public offering of 13,167,733 shares of common stock by an affiliate of General Atlantic, L.P., indicating the company's active engagement in capital markets.
- Underwriter Selection: J.P. Morgan has been appointed as the underwriter for the offering, reflecting professional support in financing, although the company will not receive any proceeds from the sale.
- Registration Statement Effective: The offering is conducted under a shelf registration statement on Form S-3 that became effective on March 2, 2026, ensuring compliance and transparency, which enhances investor confidence.
- Risk Disclosure: The company cautions investors that the completion of the offering is subject to uncertainties, potentially influenced by market conditions, regulatory changes, and other risk factors, highlighting a cautious outlook on future performance.
See More
Alignment Healthcare CEO Sells 118,000 Shares for $2.06 Million
- Transaction Overview: Alignment Healthcare CEO John E. Kao sold 118,000 shares indirectly for approximately $2.06 million, with the sale price based on SEC Form 4 at $17.48 per share, indicating stable market conditions at the time of sale.
- Ownership Structure Change: Post-transaction, Kao retains 1,784,868 shares directly and 2,354,641 shares indirectly, maintaining a total beneficial ownership of 4,139,509 shares, reflecting his ongoing confidence and control over the company.
- Historical Trading Comparison: The 118,000 shares sold are below the recent median sell size of 180,000 shares since May 2025 and below the maximum single-trade size of 605,648 shares, demonstrating the consistency of his trading activity.
- Company Growth Outlook: The company reported full-year revenue of approximately $3.95 billion in 2025, up over 46% year-over-year, with projected revenue for 2026 expected to reach $5.1 billion to $5.2 billion, highlighting strong membership growth and the focus on improving profitability despite thin margins.
See More
Alignment Healthcare CEO Sells 118,000 Shares for $2.06 Million
- Indirect Share Sale: Alignment Healthcare CEO John E. Kao sold 118,000 shares indirectly through the JEK Trust on March 23, 2026, generating approximately $2.06 million, reflecting his routine selling activity under a prearranged trading plan.
- Updated Holdings: Post-transaction, Kao's indirect holdings stand at 2,354,641 shares and direct holdings at 1,784,868 shares, maintaining over 4.1 million shares overall, indicating his continued confidence in the company's future.
- Strong Financial Performance: The company reported full-year revenue of about $3.95 billion in 2025, up more than 46% year-over-year, with adjusted EBITDA of roughly $110 million, marking a significant step towards achieving positive free cash flow.
- Growth and Profitability Challenges: While membership growth remains robust with projected revenue of $5.1 billion to $5.2 billion in 2026, the company must prioritize margin improvement to ensure a balance between sustained growth and profitability.
See More
Alignment Healthcare Prices Public Offering of 13.17M Shares
- Offering Size: Alignment Healthcare announced a public offering of 13,167,733 shares at $19.46 each, facilitated by General Atlantic, L.P., indicating ongoing market interest despite the company not receiving any proceeds from the sale.
- Closing Timeline: The offering is expected to close on March 4, 2026, pending standard closing conditions, which may influence short-term investor decisions and market liquidity.
- Financial Performance Overview: In its latest earnings report, Alignment Healthcare reported a GAAP EPS of -$0.05, beating expectations by $0.10, with revenue of $1.02 billion exceeding forecasts by $20 million, demonstrating some financial resilience amid market pressures.
- Market Competition Dynamics: Despite strong performance, the slowdown in Medicare Advantage growth, coupled with the retreat of UnitedHealth and CVS, may pose challenges to Alignment Healthcare's future growth, necessitating close monitoring of industry trends.
See More
Alignment Healthcare Prices Public Offering of 13.17 Million Shares
- Public Offering Pricing: Alignment Healthcare announced the pricing of 13,167,733 shares at $19.46 each, with the company not receiving any proceeds, yet this move is expected to enhance market liquidity.
- Underwriter Role: J.P. Morgan is acting as the underwriter for the offering, which is expected to close on March 4, 2026, subject to customary closing conditions, reflecting market confidence in the company.
- Registration Statement Validity: The offering is made pursuant to a shelf registration statement on Form S-3, which became effective on March 2, 2026, ensuring the company's compliance and transparency in capital markets.
- Future Outlook: Although the offering does not directly generate funds for the company, it is anticipated to bolster market visibility and liquidity, laying the groundwork for future expansion and market entry.
See More
ALIGNMENT HEALTHCARE INC - REVEALS SHARE OFFERING PRICE OF $19.46 FOR 13,167,733 SHARES
- Announcement of Share Offering: Alignment Healthcare Inc. has announced a share offering of 13,167,733 shares.
- Pricing Details: The shares are being offered at a price of $19.46 per share.
See More
Alignment Healthcare Launches Public Offering of 13.17 Million Shares
- Public Offering Initiated: Alignment Healthcare announced the commencement of a public offering of 13,167,733 shares of common stock by an affiliate of General Atlantic, L.P., indicating the company's active engagement in capital markets.
- Underwriter Selection: J.P. Morgan has been appointed as the underwriter for the offering, reflecting professional support in financing, although the company will not receive any proceeds from the sale.
- Registration Statement Effective: The offering is conducted under a shelf registration statement on Form S-3 that became effective on March 2, 2026, ensuring compliance and transparency, which enhances investor confidence.
- Risk Disclosure: The company cautions investors that the completion of the offering is subject to uncertainties, potentially influenced by market conditions, regulatory changes, and other risk factors, highlighting a cautious outlook on future performance.
See More
